Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Bellandi

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
American Heart Journal|June 4, 2014
Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 studyGuido Parodi, Benedetta Bellandi, Renato Valenti, et al.
European Heart Journal|August 25, 2009
Abnormal coronary reserve and left ventricular wall motion during cold pressor test in patients with previous left ventricular ballooning syndromeGiuseppe Barletta, Stefano Del Pace, Maria Boddi, et al.
Circulation. Cardiovascular Interventions|January 2, 2015
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary interventionGuido Parodi, Benedetta Bellandi, Ioanna Xanthopoulou, et al.
Journal of the American College of Cardiology|March 19, 2013
Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI studyGuido Parodi, Renato Valenti, Benedetta Bellandi, et al.
International Journal of Cardiology|April 24, 2017
Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trialGiampaolo Cerisano, Piergiovanni Buonamici, Guido Parodi, et al.
Platelets|April 15, 2021
Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomesMario E Canonico, Giuseppe D Sanna, Roberta Siciliano, et al.
International Journal of Cardiology|August 21, 2014
Residual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary interventionGuido Parodi, Benedetta Bellandi, Vincenzo Comito, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2017
Clinical events beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS studyGuido Parodi, Benedetta Bellandi, Giuseppe Tarantini, et al.
International Journal of Cardiology|July 1, 2017
APpropriateness Assessment in Antiplatelet THerapY (APATHY) registry: Insight from current clinical practiceNazario Carrabba, Benedetta Bellandi, Guido Parodi, et al.
Open Heart|November 16, 2016
Bleeding events and maintenance dose of prasugrel: BLESS pilot studyNazario Carrabba, Guido Parodi, Rossella Marcucci, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
American Heart Journal|June 4, 2014
Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 studyGuido Parodi, Benedetta Bellandi, Renato Valenti, et al.
European Heart Journal|August 25, 2009
Abnormal coronary reserve and left ventricular wall motion during cold pressor test in patients with previous left ventricular ballooning syndromeGiuseppe Barletta, Stefano Del Pace, Maria Boddi, et al.
Circulation. Cardiovascular Interventions|January 2, 2015
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary interventionGuido Parodi, Benedetta Bellandi, Ioanna Xanthopoulou, et al.
Journal of the American College of Cardiology|March 19, 2013
Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI studyGuido Parodi, Renato Valenti, Benedetta Bellandi, et al.
International Journal of Cardiology|April 24, 2017
Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trialGiampaolo Cerisano, Piergiovanni Buonamici, Guido Parodi, et al.
Platelets|April 15, 2021
Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomesMario E Canonico, Giuseppe D Sanna, Roberta Siciliano, et al.
International Journal of Cardiology|August 21, 2014
Residual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary interventionGuido Parodi, Benedetta Bellandi, Vincenzo Comito, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 21, 2017
Clinical events beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS studyGuido Parodi, Benedetta Bellandi, Giuseppe Tarantini, et al.
International Journal of Cardiology|July 1, 2017
APpropriateness Assessment in Antiplatelet THerapY (APATHY) registry: Insight from current clinical practiceNazario Carrabba, Benedetta Bellandi, Guido Parodi, et al.
Open Heart|November 16, 2016
Bleeding events and maintenance dose of prasugrel: BLESS pilot studyNazario Carrabba, Guido Parodi, Rossella Marcucci, et al.
Pageof 4